Compare $INTS vs $LTRN | Chartloom

Compare

$INTS vs $LTRN

Intensity Therapeutics Inc · Lantern Pharma Inc

INTS

Intensity Therapeutics Inc

LTRN

Lantern Pharma Inc

Compare $INTS vs $LTRN

Comparing Intensity Therapeutics Inc and Lantern Pharma Inc

INTSIntensity Therapeutics Inc

LTRNLantern Pharma Inc

INTSIntensity Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-64.3%

52W performance

-49.1%

FCF yield

-91.4%

LTRNLantern Pharma Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-73.9%

52W performance

-82.3%

FCF yield

-135.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

INTS

LTRN

Detailed metrics comparison

INTS

Intensity Therapeutics Inc

LTRN

Lantern Pharma Inc

Market Cap

INTS$10M

LTRN$10M

Enterprise Value

INTS$272K

LTRN$4M

Price

INTS$3.63

LTRN$0.81

P/E Ratio

INTSN/A

LTRNN/A

P/S Ratio

INTS0.00x

LTRN0.00x

EV/Sales

INTS0.00x

LTRN0.00x

EV/EBITDA

INTS0.00x

LTRN0.00x

P/B Ratio

INTS1.22x

LTRN3.19x

P/FCF Ratio

INTSN/A

LTRNN/A

EV/FCF

INTS-0.03x

LTRN-0.26x

PEG Ratio

INTSN/A

LTRNN/A

Forward P/E (NTM)

INTSN/A

LTRNN/A

Forward P/S (NTM)

INTSN/A

LTRNN/A

Revenue (TTM)

INTS$0

LTRN$0

Revenue Growth (YoY)

INTSN/A

LTRNN/A

Forward Rev Growth

INTS506.0%

LTRN0.0%

Gross Margin (TTM)

INTS0.0%

LTRN0.0%

Operating Margin (TTM)

INTS0.0%

LTRN0.0%

EBITDA Margin (TTM)

INTS0.0%

LTRN0.0%

Net Margin (TTM)

INTS0.0%

LTRN0.0%

FCF Margin (TTM)

INTSN/A

LTRNN/A

Net Income (TTM)

INTS$-11M

LTRN$-19M

FCF (TTM)

INTS$-9M

LTRN$-14M

EPS (TTM)

INTS-$4.12

LTRN-$1.50

ROE (TTM)

INTS-11661.0%

LTRN-19835.0%

ROA (TTM)

INTS-9401.0%

LTRN-18428.0%

ROIC (TTM)

INTS-11661.0%

LTRN-19835.0%

Cash

INTS$10M

LTRN$7M

Debt

INTS$0

LTRN$0

Net Cash/Debt

INTS$10M

LTRN$7M

Current Ratio (TTM)

INTS5.00x

LTRN1.96x

Quick Ratio (TTM)

INTS4.24x

LTRN1.70x

Debt/Equity (TTM)

INTS0.00x

LTRN0.00x

Debt/Assets (TTM)

INTS0.0%

LTRN0.0%

Interest Coverage (TTM)

INTSN/A

LTRNN/A

Net Debt/EBITDA (TTM)

INTS0.00x

LTRN0.00x

Beta

INTS3.02

LTRN2.42

52W Performance

INTS-49.1%

LTRN-82.3%

YTD Performance

INTS-64.3%

LTRN-73.9%

% from 52W High

INTS-91.7%

LTRN-82.7%

% from 52W Low

INTS13.1%

LTRN6.9%

Asset Turnover (TTM)

INTS0.00x

LTRN0.00x

FCF Yield (TTM)

INTS-91.4%

LTRN-135.8%

Earnings Yield (TTM)

INTS-113.9%

LTRN-179.9%

Dividend Yield (TTM)

INTSN/A

LTRNN/A

Rule of 40

INTS0.0

LTRN0.0

EV/GP/RG

INTSN/A

LTRNN/A

Ticker research

View INTS research View LTRN research

Metric	INTS Intensity Therapeutics Inc	LTRN Lantern Pharma Inc
Market & Valuation
Market Cap	$10M	$10M
Enterprise Value	$272K	$4M
Price	$3.63	$0.81
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.22x	3.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.03x	-0.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	506.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-11M	$-19M
FCF (TTM)	$-9M	$-14M
EPS (TTM)	-$4.12	-$1.50
ROE (TTM)	-11661.0%	-19835.0%
ROA (TTM)	-9401.0%	-18428.0%
ROIC (TTM)	-11661.0%	-19835.0%
Financial Health
Cash	$10M	$7M
Debt	$0	$0
Net Cash/Debt	$10M	$7M
Current Ratio (TTM)	5.00x	1.96x
Quick Ratio (TTM)	4.24x	1.70x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.02	2.42
52W Performance	-49.1%	-82.3%
YTD Performance	-64.3%	-73.9%
% from 52W High	-91.7%	-82.7%
% from 52W Low	13.1%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-91.4%	-135.8%
Earnings Yield (TTM)	-113.9%	-179.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View INTS research	View LTRN research

Valuation

P/S Ratio

INTS

0.00x

LTRN

0.00x

EV/FCF

LTRN

-0.26x

INTS

-0.03x

Growth & revenue

Forward Revenue Growth

INTS

506.0%

LTRN

0.0%

Profitability & performance

Gross Margin

INTS

0.0%

LTRN

0.0%

ROE

INTS

-11661.0%

LTRN

-19835.0%

FCF Yield %

INTS

-91.4%

LTRN

-135.8%

52-Week Performance

INTS

-49.1%

LTRN

-82.3%

Detailed metrics comparison

INTS

Intensity Therapeutics Inc

LTRN

Lantern Pharma Inc

Market Cap

INTS$10M

LTRN$10M

Enterprise Value

INTS$272K

LTRN$4M

Price

INTS$3.63

LTRN$0.81

P/E Ratio

INTSN/A

LTRNN/A

P/S Ratio

INTS0.00x

LTRN0.00x

EV/Sales

INTS0.00x

LTRN0.00x

EV/EBITDA

INTS0.00x

LTRN0.00x

P/B Ratio

INTS1.22x

LTRN3.19x

P/FCF Ratio

INTSN/A

LTRNN/A

EV/FCF

INTS-0.03x

LTRN-0.26x

PEG Ratio

INTSN/A

LTRNN/A

Forward P/E (NTM)

INTSN/A

LTRNN/A

Forward P/S (NTM)

INTSN/A

LTRNN/A

Revenue (TTM)

INTS$0

LTRN$0

Revenue Growth (YoY)

INTSN/A

LTRNN/A

Forward Rev Growth

INTS506.0%

LTRN0.0%

Gross Margin (TTM)

INTS0.0%

LTRN0.0%

Operating Margin (TTM)

INTS0.0%

LTRN0.0%

EBITDA Margin (TTM)

INTS0.0%

LTRN0.0%

Net Margin (TTM)

INTS0.0%

LTRN0.0%

FCF Margin (TTM)

INTSN/A

LTRNN/A

Net Income (TTM)

INTS$-11M

LTRN$-19M

FCF (TTM)

INTS$-9M

LTRN$-14M

EPS (TTM)

INTS-$4.12

LTRN-$1.50

ROE (TTM)

INTS-11661.0%

LTRN-19835.0%

ROA (TTM)

INTS-9401.0%

LTRN-18428.0%

ROIC (TTM)

INTS-11661.0%

LTRN-19835.0%

Cash

INTS$10M

LTRN$7M

Debt

INTS$0

LTRN$0

Net Cash/Debt

INTS$10M

LTRN$7M

Current Ratio (TTM)

INTS5.00x

LTRN1.96x

Quick Ratio (TTM)

INTS4.24x

LTRN1.70x

Debt/Equity (TTM)

INTS0.00x

LTRN0.00x

Debt/Assets (TTM)

INTS0.0%

LTRN0.0%

Interest Coverage (TTM)

INTSN/A

LTRNN/A

Net Debt/EBITDA (TTM)

INTS0.00x

LTRN0.00x

Beta

INTS3.02

LTRN2.42

52W Performance

INTS-49.1%

LTRN-82.3%

YTD Performance

INTS-64.3%

LTRN-73.9%

% from 52W High

INTS-91.7%

LTRN-82.7%

% from 52W Low

INTS13.1%

LTRN6.9%

Asset Turnover (TTM)

INTS0.00x

LTRN0.00x

FCF Yield (TTM)

INTS-91.4%

LTRN-135.8%

Earnings Yield (TTM)

INTS-113.9%

LTRN-179.9%

Dividend Yield (TTM)

INTSN/A

LTRNN/A

Rule of 40

INTS0.0

LTRN0.0

EV/GP/RG

INTSN/A

LTRNN/A

Ticker research

View INTS research View LTRN research

Metric	INTS Intensity Therapeutics Inc	LTRN Lantern Pharma Inc
Market & Valuation
Market Cap	$10M	$10M
Enterprise Value	$272K	$4M
Price	$3.63	$0.81
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.22x	3.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.03x	-0.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	506.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-11M	$-19M
FCF (TTM)	$-9M	$-14M
EPS (TTM)	-$4.12	-$1.50
ROE (TTM)	-11661.0%	-19835.0%
ROA (TTM)	-9401.0%	-18428.0%
ROIC (TTM)	-11661.0%	-19835.0%
Financial Health
Cash	$10M	$7M
Debt	$0	$0
Net Cash/Debt	$10M	$7M
Current Ratio (TTM)	5.00x	1.96x
Quick Ratio (TTM)	4.24x	1.70x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.02	2.42
52W Performance	-49.1%	-82.3%
YTD Performance	-64.3%	-73.9%
% from 52W High	-91.7%	-82.7%
% from 52W Low	13.1%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-91.4%	-135.8%
Earnings Yield (TTM)	-113.9%	-179.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View INTS research	View LTRN research